Keros Therapeutics, Inc. Contracts & Agreements

46 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Employment Agreement by and between the registrant and Claudia Ordonez, dated as of March 31, 2020, to be effective upon the closing of this offering
Employment Agreements
Keros Therapeutics, Inc.
Biotechnology
MA
2020
Employment Agreement by and between Keros Therapeutics, Inc. and Yung H. Chyung, dated as of October 15, 2024, effective as of November 1, 2024
Employment Agreements
Keros Therapeutics, Inc.
2024
Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Keros Therapeutics, Inc.
2024
Sales Agreement, dated May 3, 2021, by and between the Registrant and Leerink Partners (formerly SVB Leerink LLC)
Sales Agreements
Keros Therapeutics, Inc.
2024
Description of the Registrants Securities
Keros Therapeutics, Inc.
2024
Amendment No
Keros Therapeutics, Inc.
2024
Underwriting Agreement, dated January
Underwriting Agreements
Keros Therapeutics, Inc.
2024
First Amendment to Lease, by and between the Registrant and Revolution Labs Owner, LLC, dated January 6, 2023
Lease Agreements
Keros Therapeutics, Inc.
2023
Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Keros Therapeutics, Inc.
2023
Description of the Registrants Securities
Keros Therapeutics, Inc.
Biotechnology
2023
Amendment No. 2, dated as of March 11, 2022, and Amendment No. 3, dated as of December 11, 2022, to License Agreement by and between the registrant and Hansoh (Shanghai)...
License Agreements
Keros Therapeutics, Inc.
2023
Amendment to Offer Letter, dated August 1, 2022, between Jennifer Lachey and the Registrant
Keros Therapeutics, Inc.
2022
Description of the Registrants Securities
Keros Therapeutics, Inc.
Biotechnology
2022
License Agreement by and between the registrant and Hansoh (Shanghai) Healthtech Co., Ltd., dated as of December 12
License Agreements
Keros Therapeutics, Inc.
Biotechnology
NY
2022
First Amendment to the Employment Agreement by and between the registrant and Jenn Lachey, dated as of January 1, 2022
Employment Agreements
Keros Therapeutics, Inc.
2022
First Amendment to the Employment Agreement by and between the registrant and Keith Regnante, dated as of January 1, 2022
Employment Agreements
Keros Therapeutics, Inc.
2022
First Amendment to the Employment Agreement by and between the registrant and Simon Cooper, dated as of January 1, 2022
Employment Agreements
Keros Therapeutics, Inc.
Biotechnology
MA
2022
Employment Agreement by and between Keros Therapeutics, Inc. and Christopher Rovaldi, dated as of January 28, 2022, effective as of February 1, 2022
Employment Agreements
Keros Therapeutics, Inc.
Biotechnology
MA
2022
Indenture of Lease by and between the Registrant and Revolution Labs Owner, LLC, dated September 7, 2021
Indenture Agreements
Keros Therapeutics, Inc.
2021
Third Amendment to Lease Agreement by and between Keros Therapeutics, Inc. and 99 Hayden LLC, dated August 4, 2021
Lease Agreements
Keros Therapeutics, Inc.
2021
Separation and Release Agreement by and between Keros Therapeutics, Inc. and Claudia Ordonez, dated and effective as of July 30, 2021
Separation Agreements
Keros Therapeutics, Inc.
Biotechnology
MA
2021
Employment Agreement by and between Keros Therapeutics, Inc. and Simon Cooper, dated as of July 30, 2021 effective as of August 2, 2021
Employment Agreements
Keros Therapeutics, Inc.
2021
Description of
Keros Therapeutics, Inc.
Biotechnology
2021
Form of Underwriting Agreement
Underwriting Agreements
Keros Therapeutics, Inc.
2020
Form of Underwriting Agreement
Underwriting Agreements
Keros Therapeutics, Inc.
Biotechnology
NY
2020
Form of Common Stock Certificate
Stock Agreements
Keros Therapeutics, Inc.
2020
Form of Indemnity Agreement between the registrant and its directors and officers
Keros Therapeutics, Inc.
Biotechnology
DE
2020
2020 Equity Incentive Plan
Bonus & Incentive Agreements
Keros Therapeutics, Inc.
Biotechnology
DE
2020
Forms of Stock Option Grant Notice, Option Agreement, Notice of Exercise, Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement for the 2020 Equity...
Bonus & Incentive Agreements
Keros Therapeutics, Inc.
2020
2020 Employee Stock Purchase Plan
Stock Agreements
Keros Therapeutics, Inc.
Biotechnology
2020
Employment Agreement by and between the registrant and Jasbir Seehra, dated as of March 31, 2020, to be effective upon the closing of this offering
Employment Agreements
Keros Therapeutics, Inc.
2020
Employment Agreement by and between the registrant and Jenn Lachey, dated as of March 31, 2020, to be effective upon the closing of this offering
Employment Agreements
Keros Therapeutics, Inc.
Biotechnology
MA
2020
Employment Agreement by and between the registrant and Keith Regnante, dated as of March 31, 2020, to be effective upon the closing of this offering
Employment Agreements
Keros Therapeutics, Inc.
2020
Amended and Restated Investors Rights Agreement by and among the registrant and certain of its stockholders, dated as of March 2, 2020
Investor Rights Agreements
Keros Therapeutics, Inc.
Biotechnology
DE
2020
2017 Stock Incentive Plan, as amended
Bonus & Incentive Agreements
Keros Therapeutics, Inc.
2020
Form of Stock Option Grant Notice and Option Agreement for the 2017 Stock Incentive Plan, as amended
Bonus & Incentive Agreements
Keros Therapeutics, Inc.
Biotechnology
2020
2020 Equity Incentive Plan
Bonus & Incentive Agreements
Keros Therapeutics, Inc.
Biotechnology
DE
2020
Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise for the 2020 Equity Incentive Plan
Bonus & Incentive Agreements
Keros Therapeutics, Inc.
2020
2020 Employee Stock Purchase Plan
Stock Agreements
Keros Therapeutics, Inc.
Biotechnology
2020
Offer Letter Agreement by and between the registrant and Jasbir Seehra, dated as of December 14, 2015
Keros Therapeutics, Inc.
2020
Offer Letter Agreement by and between the registrant and Jenn Lachey, dated as of April 20, 2016
Keros Therapeutics, Inc.
2020
Offer Letter Agreement by and between the registrant and Claudia Ordonez, dated as of August 20, 2019
Keros Therapeutics, Inc.
Biotechnology
2020
Exclusive Patent License Agreement by and between the registrant and The General Hospital Corporation, d/b/a Massachusetts General Hospital, or MGH, dated as of April 5, 2016, as...
License Agreements
Keros Therapeutics, Inc.
2020
Research Collaboration and Exclusive License Agreement by and between the registrant and Novo Nordisk A/S, dated as of December 14, 2017
Collaboration Agreements
Keros Therapeutics, Inc.
2020
Offer Letter Agreement by and between the registrant and Keith Regnante, dated as of February 7, 2020
Keros Therapeutics, Inc.
2020
Lease Agreement by and between the registrant and 128 Spring Street Lexington, LLC, dated March 20, 2017, as amended by the First Amendment to Lease Agreement by and between the...
Lease Agreements
Keros Therapeutics, Inc.
Biotechnology
MA
2020